Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study-Reference-Cited by-同舟云学术

Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study

Published:2015-09-15 Issue:7 Volume:75 Page:1336-1342
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Gabay Cem,Riek Myriam,Hetland Merete Lund,Hauge Ellen-Margrethe,Pavelka Karel,Tomšič Matija,Canhao Helena,Chatzidionysiou Katerina,Lukina Galina,Nordström Dan C,Lie Elisabeth,Ancuta Ioan,Hernández M Victoria,van Riel Piet L M C,van Vollenhoven Ronald,Kvien Tore K

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference19 articles.

1. Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial;Smolen;Lancet,2008

2. IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial;Emery;Ann Rheum Dis,2008

3. Tocilizumab inhibits structural joint damage and improves physical function in patients with rheumatoid arthritis and inadequate responses to methotrexate: LITHE study 2-year results;Fleischmann;J Rheumatol,2013

4. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update;Smolen;Ann Rheum Dis,2014

5. The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment;Breedveld;Arthritis Rheum,2006

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathogenic mechanisms of cardiovascular damage in COVID-19;Molecular Medicine;2024-06-19

2. Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: Results from the international TOCERRA and PANABA observational collaborative studies;Joint Bone Spine;2024-03

3. A national, multicenter, retrospective study evaluating retention rate and efficacy of tocilizumab treatment in patients with active rheumatoid arthritis who had an inadequate response to csDMARDs and/or TNF inhibitors;Turkish Journal of Medical Sciences;2023-01-01

4. Comparison of Biological Agent Monotherapy and Associations Including Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis: Literature Review and Meta-Analysis of Randomized Trials;Journal of Clinical Medicine;2022-12-29

5. Evaluation of Drugs and Strategies for Treating Coronary Artery Ectasia: Update and Future Perspective;Jundishapur Journal of Chronic Disease Care;2022-06-06